SITALA

Serial Number 79348421
Registration 7256721
700

Registration Progress

Application Filed
May 19, 2022
Under Examination
Approved for Publication
Oct 17, 2023
Published for Opposition
Oct 17, 2023
Registered
Jan 2, 2024

Trademark Image

SITALA

Basic Information

Serial Number
79348421
Registration Number
7256721
Filing Date
May 19, 2022
Registration Date
January 2, 2024
Published for Opposition
October 17, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 2, 2024
Registration
Registered
Classes
042

Rights Holder

Sitala Bio Ltd

99
Address
Unit D6, Grain House Mill Court,
Great Shelford Cambridge CB22 5LD
GB

Ownership History

Sitala Bio Ltd

Original Applicant
99
GB

Sitala Bio Ltd

Owner at Publication
99
GB

Sitala Bio Ltd

Original Registrant
99
GB

Legal Representation

Attorney
Tanja Proehl

USPTO Deadlines

Next Deadline
1609 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-01-02)
Due Date
January 02, 2030
Grace Period Ends
July 02, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Apr 29, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Apr 5, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Apr 4, 2024 FIMP P FINAL DISPOSITION PROCESSED Loading...
Apr 2, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jan 2, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 2, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 17, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 16, 2023 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Sep 27, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Sep 27, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 27, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Sep 8, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 15, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 15, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 15, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 6, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
May 12, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
May 12, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 24, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 23, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 9, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 10, 2023 CORR I CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED Loading...
Oct 24, 2022 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB Loading...
Sep 6, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Sep 2, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 1, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 042
Development of pharmaceutical preparations and medicines; pharmaceutical drug development services; laboratory research services in the field of pharmaceuticals; clinical research in the field of chronic inflammation, inflammation and inflammatory diseases; medical research; conducting of clinical trials for pharmaceutical products in the field of chronic inflammation, inflammation and inflammatory diseases; pharmaceutical product evaluation services; testing of pharmaceuticals; pharmaceutical research and development services; information, consultancy and advisory services relating to all of the aforesaid

Classification

International Classes
042